- Tytuł:
- End-of-treatment 18[F]-FDG PET can predict early progression in patients receiving bendamustine-rituximab for follicular lymphoma in first relapse: a prospective West Japan hematology Study Group (W-JHS) NHL01 trial
- Autorzy:
- Źródło:
- International Journal of Hematology. :1-9
Czasopismo naukowe